One children’s hospital planning and development process to adhere to the FDA recommendation that babies and young children undergo thyroid function testing after receiving an injection of iodine-containing contrast media for medical imaging
The United States (US) Food and Drug Administration (FDA) has issued multiple statements and guidelines since 2015 on the topic of thyroid function testing in babies and children through 3 years old after receiving iodinated contrast media for medical imaging exams. In April 2023, the FDA adjusted this recommendation to target babies and young children younger than 4 years of age who have a history of prematurity, very low birth weight, or underlying conditions which affect thyroid gland function, largely in response to solid arguments from expert statements from the American College of Radiology (ACR) which is endorsed by the Society for Pediatric Radiology (SPR), Pediatric Endocrinology Society (PES), and the Society for Cardiovascular Angiography & Intervention (SCAI). Herein we describe our approach and development of a clinical care guideline along with the steps necessary for implementation of the plan including alterations in ordering exams requiring iodinated contrast media, automatic triggering of lab orders, reporting, and follow-up, to address the 2022 FDA guidance statement to monitor thyroid function in children after receiving iodinated contrast media. The newly implemented clinical care guideline at Ann and Robert H. Lurie Children’s Hospital of Chicago remains applicable following the 2023 updated recommendation from the FDA. We will track patients less than 3 months of age who undergo thyroid function testing following computed tomography (CT), interventional radiology, and cardiac catheterization exams for which an iodinated contrast media is administered as a clinical care quality initiative. Graphical Abstract.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:54 |
|---|---|
| Enthalten in: |
Pediatric radiology - 54(2023), 1 vom: 29. Nov., Seite 27-33 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bardo, Dianna M. E. [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
Child |
|---|
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
|---|
| doi: |
10.1007/s00247-023-05806-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR054318831 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR054318831 | ||
| 003 | DE-627 | ||
| 005 | 20240110064633.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240110s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00247-023-05806-3 |2 doi | |
| 035 | |a (DE-627)SPR054318831 | ||
| 035 | |a (SPR)s00247-023-05806-3-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bardo, Dianna M. E. |e verfasserin |0 (orcid)0000-0003-4634-9307 |4 aut | |
| 245 | 1 | 0 | |a One children’s hospital planning and development process to adhere to the FDA recommendation that babies and young children undergo thyroid function testing after receiving an injection of iodine-containing contrast media for medical imaging |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
| 520 | |a The United States (US) Food and Drug Administration (FDA) has issued multiple statements and guidelines since 2015 on the topic of thyroid function testing in babies and children through 3 years old after receiving iodinated contrast media for medical imaging exams. In April 2023, the FDA adjusted this recommendation to target babies and young children younger than 4 years of age who have a history of prematurity, very low birth weight, or underlying conditions which affect thyroid gland function, largely in response to solid arguments from expert statements from the American College of Radiology (ACR) which is endorsed by the Society for Pediatric Radiology (SPR), Pediatric Endocrinology Society (PES), and the Society for Cardiovascular Angiography & Intervention (SCAI). Herein we describe our approach and development of a clinical care guideline along with the steps necessary for implementation of the plan including alterations in ordering exams requiring iodinated contrast media, automatic triggering of lab orders, reporting, and follow-up, to address the 2022 FDA guidance statement to monitor thyroid function in children after receiving iodinated contrast media. The newly implemented clinical care guideline at Ann and Robert H. Lurie Children’s Hospital of Chicago remains applicable following the 2023 updated recommendation from the FDA. We will track patients less than 3 months of age who undergo thyroid function testing following computed tomography (CT), interventional radiology, and cardiac catheterization exams for which an iodinated contrast media is administered as a clinical care quality initiative. Graphical Abstract | ||
| 650 | 4 | |a Child |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Contrast media |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Premature infant |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Thyroid function tests |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Very low birth weight |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Samis, Jill H. |0 (orcid)0000-0001-9369-1661 |4 aut | |
| 700 | 1 | |a Josefson, Jami L. |0 (orcid)0000-0003-0339-0166 |4 aut | |
| 700 | 1 | |a Malakooti, Marcelo R. |0 (orcid)0000-0002-2650-2960 |4 aut | |
| 700 | 1 | |a Tannous, Paul |0 (orcid)0000-0001-7972-9651 |4 aut | |
| 700 | 1 | |a Fox, Jeremy L. |0 (orcid)0000-0002-4231-6164 |4 aut | |
| 700 | 1 | |a Elhadary, Jennifer |4 aut | |
| 700 | 1 | |a Eichstaedt, Amanda |4 aut | |
| 700 | 1 | |a Gray, Kenneth |4 aut | |
| 700 | 1 | |a Nytko, Agata |4 aut | |
| 700 | 1 | |a Rigsby, Cynthia K. |0 (orcid)0000-0003-1224-2333 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pediatric radiology |d Berlin : Springer, 1973 |g 54(2023), 1 vom: 29. Nov., Seite 27-33 |w (DE-627)SPR00281482X |w (DE-600)1463007-2 |x 1432-1998 |7 nnns |
| 773 | 1 | 8 | |g volume:54 |g year:2023 |g number:1 |g day:29 |g month:11 |g pages:27-33 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00247-023-05806-3 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 54 |j 2023 |e 1 |b 29 |c 11 |h 27-33 | ||